Artificial neural network for prediction of antigenic activity for a major conformational epitope in the hepatitis C virus NS3 protein.

Artificial neural network for prediction of antigenic activity for a major conformational epitope in the hepatitis C virus NS3 protein. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Artificial neural network for prediction of antigenic activity for a major conformational epitope in the hepatitis C virus NS3 protein. Abstract Text:

MOTIVATION: Insufficient knowledge of general principles for accurate quantitative inference of biological properties from sequences is a major obstacle in the rationale design of proteins with predetermined activities. Due to this deficiency, protein engineering frequently relies on the use of computational approaches focused on the identification of quantitative structure-activity relationship (SAR) for each specific task. In the current article, a computational model was developed to define SAR for a major conformational antigenic epitope of the hepatitis C virus (HCV) non-structural protein 3 (NS3) in order to facilitate a rationale design of HCV antigens with improved diagnostically relevant properties. RESULTS: We present an artificial neural network (ANN) model that connects changes in the antigenic properties and structure of HCV NS3 recombinant proteins representing all 6 HCV genotypes. The ANN performed quantitative predictions of the enzyme immunoassay (EIA) Signal/Cutoff (S/Co) profiles from sequence information alone with 89.8% accuracy. Amino acid positions and physicochemical factors strongly associated with the HCV NS3 antigenic properties were identified. The positions most significantly contributing to the model were mapped on the NS3 3D structure. The location of these positions validates the major associations found by the ANN model between antigenicity and structure of the HCV NS3 proteins. AVAILABILITY: Matlab code is available at the following URL address: http://bio-ai.myeweb.net/box_widget.html

Artificial neural network for prediction of antigenic activity for a major conformational epitope in the hepatitis C virus NS3 protein. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Artificial neural network for prediction of antigenic activity for a major conformational epitope in the hepatitis C virus NS3 protein. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Bioinformatics (Oxford, England)

VOLUME: 24

Page Numbers: 1858-64

Journal Abbreviation: Bioinformatics

ISSN: 1460-2059

DAY: 15

MONTH: 07

YEAR: 2008

Artificial neural network for prediction of antigenic activity for a major conformational epitope in the hepatitis C virus NS3 protein. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9808944

Artificial neural network for prediction of antigenic activity for a major conformational epitope in the hepatitis C virus NS3 protein. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Artificial neural network for prediction of antigenic activity for a major conformational epitope in the hepatitis C virus NS3 protein. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Artificial neural network for prediction of antigenic activity for a major conformational epitope in the hepatitis C virus NS3 protein.

AFFILIATION: Division of Viral Hepatitis and Biotechnology Core Facility, Division of Scientific Resources, Centers for Disease Control and Prevention, 1600 Clifton Road MS A33, Atlanta, GA, 30333, USA. jlara@cdc.gov

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Bioinformatics

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Artificial neural network for prediction of antigenic activity for a major conformational epitope in the hepatitis C virus NS3 protein Related Publications

• A new enzyme immunoassay for the detection of antibody to hepatitis E virus.
• A new method for preservation of viable leukocytes at near-zero temperatures.
• Artificial neural network for prediction of antigenic activity for a major conformational epitope in the hepatitis C virus NS3 protein.
• Coordinated evolution of the hepatitis C virus.
• End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: Performance under optimal and suboptimal conditions.
• Supragenotypic groups of the hepatitis B virus genome.
• TT virus infection among Egyptian patients with hepatocellular carcinoma.